PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 29, 2026Journal of the Pediatric Infectious Diseases Society0 citations

Respiratory bacterial epidemiology at three primary ciliary dyskinesia clinical centers

View Full Paper
AZAmanda ZiminskiMZMadsen ZimbricHMHarlan McCaffery

Key Points

  • This study aims to characterize bacterial epidemiology in primary ciliary dyskinesia across clinical centers, focusing on Pseudomonas aeruginosa prevalence.
  • Retrospective observational study assessing period prevalence and chronic infection rates of bacteria at three pediatric PCD Centers and one adult Center.
  • Data analyzed using Fisher’s exact test and Bayesian mixed-effects logistic regression for between-center comparisons.
  • Cohorts included 41 pediatric patients from Standard Precautions center, 25 from clinic cohorting, and 30 from CF-IPC center.
  • P. aeruginosa prevalence at Centers A, B, and C was 37%, 32%, and 47%, respectively (p = 0.55).
  • Significantly higher Haemophilus influenzae prevalence was found at Center A compared to others (p=0.001), with chronic infection rates showing p<0.0001.
  • Age-stratified analysis indicated increasing P. aeruginosa prevalence from age 10, while H. influenzae prevalence declined.

Abstract

Abstract Background Primary ciliary dyskinesia (PCD) is a rare congenital disorder marked by impaired motile ciliary function, resulting in chronic oto-sino-pulmonary infections, including Pseudomonas aeruginosa . While enhanced infection prevention and control (IPC) practices have successfully reduced P. aeruginosa prevalence and transmission in cystic fibrosis (CF), comparable IPC strategies have not been evaluated in PCD. This study aimed to characterize bacterial epidemiology across PCD Clinical Centers, hypothesizing that P. aeruginosa prevalence would be higher at centers lacking enhanced IPC measures. Methods We performed a retrospective observational study assessing the period prevalence and chronic infection rates of P. aeruginosa and other respiratory microorganisms at three pediatric PCD Centers and one adult Center. Between-center comparisons of patients ever infected status used Fisher’s exact test, with age-adjusted repeated-measures analyses conducted via Bayesian mixed-effects logistic regression. Results The cohort included 41 pediatric patients from Center A (Standard Precautions), 25 from Center B (clinic cohorting), and 30 from Center C (enhanced IPC based on CF Foundation Guidelines, CF-IPC). An additional 13 adult patients from Center A were included for descriptive analysis only. P. aeruginosa period prevalence at pediatric Centers A, B, and C was 37%, 32%, and 47%, respectively (p = 0.55). In contrast, pediatric Haemophilus influenzae prevalence (p=0.001) and chronic H. influenzae infection rates (p0.0001) were significantly higher at Center A compared with Centers B and C. Age-stratified analysis across all pediatric Centers demonstrated increasing P. aeruginosa prevalence beginning around age 10, while H. influenzae prevalence declined with age. Nearly 85% of adults had a history of P. aeruginosa infection. Conclusions Our findings suggest that CF- IPC protocols may not exert the same influence on bacterial epidemiology in PCD as they do in CF. P. aeruginosa may be more prevalent in PCD than previously recognized, and variations in IPC strategies were not significantly associated with differences in P. aeruginosa rates across pediatric PCD Centers.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ziminski et al. (2026) studied this question.

synapsesocial.com/papers/6a420ba8f91bb43ea9192a1ahttps://doi.org/10.1093/jpids/piag048
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Haemophilus influenzae in bronchiectasis2025 · 12 citations
  2. 2The Prevalence and Significance of Staphylococcus aureus in Patients with Non–Cystic Fibrosis Bronchiectasis2018 · 49 citations
  3. 3Role of Stenotrophomonas maltophilia isolation in patients with non-CF bronchiectasis2020 · 14 citations
  4. 4Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update2014 · 389 citations
  5. 5The natural history and genetic diversity of Haemophilus influenzae infecting the airways of adults with cystic fibrosis2022 · 12 citations